All Articles

Pages of clinicians and researchers statement showing names and logos

Hepatitis Experts Welcome ATAGI Statement on Hepatitis B Birth Dose Vaccination

Australia’s hepatitis experts have welcomed a new statement from the Australian Technical Advisory Group on Immunisation (ATAGI) confirming the importance and safety of administering the hepatitis B vaccine at birth. Responding to…

Abandoning Hepatitis B Vaccines for Babies is Bad Science and Bad Medicine

Hepatitis Australia, ASHM and the Australian Technical Group on Immunisation (ATAGI) are urging Australians to maintain routine hepatitis B vaccinations for newborns following the alarming news that the advisory panel…

Community Leaders Share Concerns About Hepatitis B and the Law

Hepatitis B is Australia’s most prevalent blood-borne virus, with nearly 220,000 people estimated to be living with chronic infection. In a recent report called ‘If Hepatitis was 100 People’, Hepatitis…

Wait! There’s more…

Hepatitis is not often seen as a health issue for children – but as shown in Community News #107, children can be at risk of hepatitis or hepatitis-related health issues…

Treating Fibrosis with Henna

Henna is natural dye, orange-red in colour, made from the powdered leaves of Lawsonia inermis and was being used in body art, and as a dye for hair, nails and…

A Single-Dose Cure for Hep B?

Hepatitis B remains a global public health problem, even in countries like Australia with universal childhood vaccination. For people who have been infected, and who now live with chronic hepatitis B,…

Tasmania to pilot national hepatitis C awareness campaign

The Australian Government is funding a new hepatitis C awareness campaign to be piloted in Tasmania, as part of national efforts to identify and treat people who may be living with the…

Spreading the Word about Hepatitis B and D

Adrian Hicks wants to shout out to the world: If you have hepatitis B, don’t ignore it… do something, your life may depend on it! Adrian lives with not one…

In Our Library: October 2025 Highlights

HepSA Library October acquisition highlights: HBV surveillance, managing hep B, hep D advances, and more…

UK Shows the Power of Opt-Out Testing

Thousands of Britons have been found to have been living with previously undiagnosed hepatitis and HIV under a new testing system recently introduced in accident and emergency departments by the…

Understanding Clinical Trials in MASLD

Involvement in a clinical trial may provide access to new treatments and provide participants with a higher level of clinical care, which many people with fatty liver find beneficial.

Pig-to-Human Liver Transplant Shows Mixed Success

Part of a liver from a genetically engineered pig has been transplanted into a living human recipient, who then survived a further six months before dying from repeated upper gastrointestinal…

While We Wait for a Hepatitis B Cure – Screen More, Treat More, Treat Earlier

The hepatitis B virus (HBV) is notoriously hard to get rid of. The virus embeds its covalently closed circular DNA (the cccDNA) in the liver, integrating itself into the host…

My Health Record: BBV results now recorded by default

Recent changes to the processing of pathology reports for My Health Record has elevated the importance of pre-test counselling...

In Our Library: Life after hepatitis C

Challenges threaten to undermine the individual and public health gains provided by long-awawited hep C cures.

On the Ground – Great New Location for Uniting Communities U City NSP

Uniting Communities, its partner agencies and supporters celebrated the opening of a new ground floor space within the U City on Franklin Street.

How Machine Learning Can Help Discover Anti-Hepatitis C Drugs

Finding a single novel molecule for drug development can take years. Machine learning can help process billions of molecules in a day, and aid drug discovery against viral illnesses that…

High Hep C Cure Rate Among NSP Clients

Findings from the Australian Needle and Syringe Program (NSP) Survey 30-year National Data Report shows highly significant reductions in hepatitis C infections and high levels of treatment and cure among…

Birth-Dose Vaccination Crucial to Prevention of Chronic Hepatitis B in Children

Hepatitis Australia and ASHM have released a statement reminding all Australians of the importance of hepatitis B vaccinations to protect the health and wellbeing of children. The statement pointed out…

Hepatitis B and C: A call to action for nurses and midwives

By Mieken Grant, originally published in the Australian Nursing & Midwifery Journal, and reprinted with permission. In Australia, just under 300,000 people live with chronic hepatitis B or hepatitis C,…

Cutting Out Hep B with ‘Molecular Scissors’

A genetic peculiarity that is sometimes found in biochemistry is ‘covalently closed circular DNA‘ (cccDNA), where the DNA molecule, instead of being a long, ribbon-like strand, becomes a closed loop.…

In Our Library: August 2025 Highlights

HepSA Library August acquisition highlights: Peer Workforce Framework, If Hepatitis Was 100 People, NSP Research and more… Click on the images to access or view all resources added in the last month.…

Hep C & Mental Illness: New Link Discovered

The blood–brain barrier is a hugely effective “wall” that protects the brain from pathogens in a person’s body. It’s like a highly selective, very fine sieve that allows vital nutrients…

How Hep B Research Helped when COVID-19 Hit

As the coronavirus spread globally in 2020, and people all around the world began to be uncomfortably familiar with RAT tests and PCR tests, NSW historian Michelle Bootcov realised her…